[Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
D000328:Adult; D002749:Chlorprothixene / Q000627:therapeutic use*; D003006:Clopenthixol / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D009912:Oral Manifestations; D010259:Paranoid Disorders / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014966:Xanthenes / Q000009:adverse effects / Q000627:therapeutic use*
D010276:Parasympatholytics; D010879:Piperazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D003006:Clopenthixol; D002749:Chlorprothixene
Vergleichende klinisch-psychiatrische Erfahrungen mit Thiaxanthen-Derivaten unter besonderer Berücksichtigung von Flupenthixol.